Rifampin Drug-Drug Interaction Study With Lurasidone HCl

NCT01082276 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sumitomo Pharma America, Inc.